EFX
Equifax Inc.
EFX has the edge over RKLB overall, supported by lower modeled downside and stronger valuation.
RKLB
Rocket Lab USA, Inc.
RKLB offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
EFX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Stable |
EFX's revenue, profitability and cash flow are currently healthy, and its balance sheet is stable.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
EFX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $187 | — |
| Current | 30x | $187 | — |
| Cheap | 34x | $208 | +11% |
| Fair | 46x | $287 | +54% |
| Expensive | 58x | $359 | +92% |
Historical ranges are pointers, not guarantees.
EFX's PE is in its cheap range at 30x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
EFX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for EFX, with profitability improving.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
EFX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.06 | +46% |
| Q3 2026 | $6.19 | +17% |
| Q2 2026 | $5.69 | +11% |
| Q1 2026 | $5.68 | +16% |
| Q4 2025 | $5.32 | +9.9% |
| Q3 2025 | $5.28 | +17% |
| Q2 2025 | $5.12 | +9.4% |
| Q1 2025 | $4.90 | +9.1% |
| Q4 2024 | $4.84 | +10% |
EFX has the edge over RKLB on earnings quality, reporting a profit while its opponent remains loss making.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
EFX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.7B | +9.6% |
| Q2 2026 | $1.7B | +11% |
| Q1 2026 | $1.6B | +14% |
| Q4 2025 | $1.6B | +9.2% |
| Q3 2025 | $1.5B | +7.2% |
| Q2 2025 | $1.5B | +7.4% |
| Q1 2025 | $1.4B | +3.8% |
| Q4 2024 | $1.4B | +7% |
EFX's revenue has grown year over year for 14 quarters in a row: $1.7B last quarter, up 9.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | +3.9 points |
| Q2 2026 | 18% | -1.7 points |
| Q1 2026 | 17% | +1.1 points |
| Q4 2025 | 18% | -2 points |
| Q3 2025 | 17% | 0 points |
| Q2 2025 | 20% | +0.5 points |
| Q1 2025 | 16% | +0.2 points |
| Q4 2024 | 20% | +1.8 points |
EFX has the edge over RKLB on profitability, with a higher operating margin.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over EFX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB's operating margin was −30% last quarter, up 8.5 points from the same quarter a year ago.
EFX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $436.9M | -0.2% |
| Q2 2026 | $204.8M | -14% |
| Q1 2026 | $121.5M | +4.1% |
| Q4 2025 | $340.8M | +66% |
| Q3 2025 | $437.9M | +23% |
| Q2 2025 | $238.9M | +83% |
| Q1 2025 | $116.7M | -3.4% |
| Q4 2024 | $205.9M | +17% |
EFX has the edge over RKLB on cash generation, producing positive trailing cash flow while its opponent burns cash.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
EFX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.5x | Moderate |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.7x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 2.6x | Moderate |
| Q2 2025 | 2.7x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.8x | Moderate |
EFX's net debt is about 2.5 years of its operating earnings (EBITDA), about the same as a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EFX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.3 | Neutral |
| Stochastic | 82.1 | Overbought |
EFX's weekly RSI is 55 (neutral) and its Stochastic is 82 (overbought).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
EFX PE vs Industrials Sector
| Metric | EFX | Sector median | Relative |
|---|---|---|---|
| PE | 30x | 24x | 25% above |
| PE % | 7 | 58 | 51 pts below |
EFX is trading at 30x earnings, a 25% premium to the Industrials sector's median of 24x.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
EFX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $167.3 | 12% above |
| 20 week MA | $172.7 | 8.1% above |
| 50 week MA | $183.0 | 2% above |
| 100 week MA | $214.7 | 13% below |
| 200 week MA | $224.3 | 17% below |
EFX has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 17% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB's trend is mixed: it's above three of its five weekly moving averages, and 104% above its 200-week average.
EFX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $140.2 | $194.0 | +38% |
| 2021 | $194.0 | $287.0 | +48% |
| 2022 | $287.0 | $195.7 | -32% |
| 2023 | $195.7 | $247.3 | +26% |
| 2024 | $247.3 | $256.0 | +3.5% |
| 2025 | $256.0 | $222.1 | -13% |
| 2026 YTD | $222.1 | $186.8 | -16% |
EFX has finished higher in four of the last six years. It's down 16% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over EFX on returns for 2026, with the stronger performance.